Pharmacoeconomics of novel pharmacotherapies in triple-negative breast cancer.

Boscolo Bielo, Luca; Trapani, Dario; Curigliano, Giuseppe

Boscolo Bielo, Luca; Trapani, Dario; Curigliano, Giuseppe.

Afiliação

Boscolo Bielo L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy.
Trapani D; Department of Oncology and Haematology, University of Milan, Milan, Italy.
Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy.

Expert Opin Pharmacother ; 24(7): 789-801, 2023 May.

Article em En | MEDLINE | ID: mdl-37029518

Assuntos

Neoplasias de Mama Triplo Negativas; Humanos; Neoplasias de Mama Triplo Negativas/tratamento farmacológico; Farmacoeconomia; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Terapia de Alvo Molecular

Palavras-chave

Antibodydrug conjugates; PARP inhibitors; breast cancer; cost-effectiveness; costutility; immunotherapy; pharmacoeconomics; triple-negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Revista: Expert Opin Pharmacother Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google